Is It Time to Buy the Dow Jones' 3 Worst-Performing February Stocks? | The Motley Fool
The Motley Fool· 4 days agoFebruary was another good month for blue chip stocks, with the Dow Jones Industrial Average gaining...
Where Will Pfizer Be in 1 Year? | The Motley Fool
The Motley Fool· 5 days agoFor the company, though, 2020 was about transformation. Management is hoping to reestablish Pfizer as a scientific trailblazer after shedding slow-growth...
Drugs That Slow RA's Progress
WebMD· 6 days agoYou can't miss the telltale signs: painful and swollen joints that get worse over time. Painkillers and drugs that fight inflammation can treat your...
A Big Law Trial Lawyer’s Story of Pain, Loss and Healing | Litigation Daily | The American Lawyer
Law.com· 4 days agoWhat if you had to walk away from your career, right at its height, because of a debilitating...
RA Experts Highlight Key Developments Over the Past Year
Medscape· 2 days agoA massive Swedish cohort study suggesting that biologic agents reduce the known excess risk of...
Amgen (AMGN) Down 5.5% Since Last Earnings Report: Can It Rebound?
Zacks via Yahoo Finance· 3 days agoIt has been about a month since the last earnings report for Amgen (AMGN). Will the recent negative...
Amgen (AMGN) to Add Stomach Cancer Drug With Five Prime Buyout
Zacks via Yahoo Finance· 2 days agoAmgen Inc. AMGN announced an agreement to acquire clinical-stage, cancer-focused biotechnology...
Drug Discovery Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021
Digital Journal· 2 days agoAmid the COVID-19 pandemic, the health system of countries is rapidly investing in research and development to combat the virus. Potential compounds were screened from the CHEMBL database, ZINC ...
Pharmacy benefits manager Abarca inks discount deal for Amgen's Enbrel
Reuters via Yahoo News· 1 year agoPharmacy benefits managers like Abarca act as middlemen in the drug supply chain, and negotiate...
Amgen Wins Enbrel U.S. Patent Litigation Against Novartis
Zacks via Yahoo Finance· 2 years agoAmgen Inc. AMGN announced that a district court of New Jersey has upheld the validity of its two...